Renal Cell Carcinoma–Associated Diabetes Mellitus Due to Paraneoplastic Syndrome in Maintenance Hemodialysis: A Case Report

Palapattu, 2002, Paraneoplastic syndromes in urologic malignancy: the many faces of renal cell carcinoma, Rev Urol, 4, 163 Spyridopoulos, 2012, Insulin resistance and risk of renal cell cancer: a case-control study, Hormones (Athens), 11, 308, 10.14310/horm.2002.1359 Okada, 2019, IL-6-producing renal cell carcinoma causing renal and endocrine paraneoplastic syndromes, Intern Med, 58, 1953, 10.2169/internalmedicine.2000-18 Blay, 1997, Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma, Int J Cancer, 72, 424, 10.1002/(SICI)1097-0215(19970729)72:3<424::AID-IJC9>3.0.CO;2-R Elias, 2005, New-onset insulinopenic diabetes mellitus in a patient with an incidentally discovered renal cell carcinoma, Am J Med, 118, 1047, 10.1016/j.amjmed.2005.03.009 Khanna, 2021, Glucagon-producing mucinous tubular and spindle cell variant of renal cell carcinoma with paraneoplastic diabetes: case report and review of literature, Indian J Urol, 37, 176, 10.4103/iju.IJU_265_20 Gapp, 2018, New onset hyperglycemia attributed to renal cell carcinoma, Intractable Rare Dis Res, 7, 134, 10.5582/irdr.2018.01034 Noda-Narita, 2021, Paraneoplastic polymyositis due to renal cell carcinoma in a patient with autosomal dominant polycystic kidney disease, Intern Med, 60, 3577, 10.2169/internalmedicine.7417-21 Terakawa, 2021, Renal squamous cell carcinoma-related polymyositis in a patient with autosomal dominant polycystic kidney disease, Intern Med, 60, 1237, 10.2169/internalmedicine.5375-20 Kondo, 2018, Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: central pathology results according to the 2016 WHO classification in a multi-institutional study, Pathol Int, 68, 543, 10.1111/pin.12718 Nishimura, 2020, Pulmonary manifestations of plasma cell type idiopathic multicentric Castleman disease: a clinicopathological study in comparison with IgG4-related disease, J Pers Med, 10, 269